Agilent Revenues Up 16 Percent in Q2, Swings to Profit

The company said that the Varian purchase, completed last week, is expected to add $370 million in revenue for the second half of its fiscal-year 2010, 30 percent of which would go to Life Sciences.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories